B. abortus RNA is the component involved in the down-modulation of MHC-I expression on human monocytes via TLR8 and the EGFR pathway
Open Access
- 2 August 2017
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 13 (8) , e1006527
Abstract
Despite eliciting a potent CD8+ T cell response, Brucella abortus is able to persist and establish a chronic infection inside its host. We have previously reported that the infection of human monocytes/macrophages with B. abortus inhibits the IFN-γ-induced MHC-I cell surface expression down-modulating cytotoxic CD8+ T cell responses. MHC-I down-modulation depends on bacterial viability and results from the capacity of B. abortus to retain the MHC-I molecules within the Golgi apparatus. Furthermore, we recently demonstrated that epidermal growth factor receptor (EGFR) pathway is involved in this phenomenon and that this is an early event during infection. However, the components and mechanisms whereby B. abortus is able to down-modulate MHC-I remained to be elucidated. In this study we demonstrated that the down-modulation of MHC-I expression is not mediated by well-known Brucella virulence factors but instead by B. abortus RNA, a PAMP associated to viability (vita-PAMP). Surprisingly, completely degraded RNA was also able to inhibit MHC-I expression to the same extent as intact RNA. Accordingly, B. abortus RNA and its degradation products were able to mimic the MHC-I intracellular retention within the Golgi apparatus observed upon infection. We further demonstrated that TLR8, a single-stranded RNA and RNA degradation products sensor, was involved in MHC-I inhibition. On the other hand, neutralization of the EGFR reversed the MHC-I inhibition, suggesting a connection between the TLR8 and EGFR pathways. Finally, B. abortus RNA-treated macrophages display diminished capacity of antigen presentation to CD8+ T cells. Overall, our results indicate that the vita-PAMP RNA as well as its degradation products constitute novel virulence factors whereby B. abortus, by a TLR8-dependent mechanism and through the EGFR pathway, inhibits the IFN-γ-induced MHC-I surface expression on human monocytes/macrophages. Thus, bacteria can hide within infected cells and avoid the immunological surveillance of cytotoxic CD8+ T cells. Brucella abortus is one of the intracellular bacterial species that cause brucellosis, a zoonotic worldwide disease. An intricate enigma of Brucella immunity is its long-term persistence inside host despite a vigorous and specific immune response. Our study describes a novel immune evasion strategy exploited by B. abortus: the down-modulation of the IFN-γ-induced expression of the molecules responsible for antigen presentation to CD8+ T cells on the surface of monocytes, Major Histocompatibility Complex Class I (MHC-I) molecules. We found that the bacterial component responsible for this phenomenon is its RNA, a component associated with bacterial viability itself. Specifically, we demonstrated that not only does intact RNA down-modulate MHC-I but also the RNA degradation products. Bacterial RNA is sensed by pattern recognition receptors (PRRs), among which TLRs family has gained more attention. In this study, we demonstrated that the receptor involved in this phenomenon is TLR8, a single-stranded RNA and RNA degradation products sensor. By means of this mechanism, Brucella impairs antigen presentation to CD8+ T cells, hiding within infected cells and avoiding the immunological surveillance of cytotoxic cells. On balance, these results provide new evidence to understand how B. abortus can survive inside the host and persist chronically.Keywords
Funding Information
- Agencia Nacional de Promoción Científica y Tecnológica (ANPCYT-Argentina) (PICT 2011-1420)
- Agencia Nacional de Promoción Científica y Tecnológica (ANPCYT-Argentina) (PICT 2013-0162)
- Agencia Nacional de Promoción Científica y Tecnológica (ANPCYT-Argentina) (PICT 2011-1200)
- Agencia Nacional de Promoción Científica y Tecnológica (ANPCYT-Argentina) (PICT 2012-2252)
- Agencia Nacional de Promoción Científica y Tecnológica (ANPCYT-Argentina) (PICT 2014-1925)
- CONICET (Argentina) (PIP 1390)
- CONICET (Argentina) (PIP 0373)
- UBACYT (Argentina) (20020130200030)
- UBACYT (Argentina) (20020120100128)
- Fundación Alberto J. Roemmers (AR) (2012-2014)
This publication has 47 references indexed in Scilit:
- Inhibition of MHC‐I by Brucella abortus is an early event during infection and involves EGFR pathwayImmunology & Cell Biology, 2016
- Brucella abortusinduces intracellular retention of MHC-I molecules in human macrophages down-modulating cytotoxic CD8+T cell responsesCellular Microbiology, 2012
- Detection of prokaryotic mRNA signifies microbial viability and promotes immunityNature, 2011
- Cell-mediated immunity in human brucellosisMicrobes and Infection, 2011
- Host Immune Responses to the Intracellular Bacteria Brucella: Does the Bacteria Instruct the Host to Facilitate Chronic Infection?Critical Reviews in Immunology, 2006
- BrucellaEvades Macrophage Killing via VirB-dependent Sustained Interactions with the Endoplasmic ReticulumJournal of Experimental Medicine, 2003
- Role of the Brucella suis Lipopolysaccharide O Antigen in Phagosomal Genesis and in Inhibition of Phagosome-Lysosome Fusion in Murine MacrophagesInfection and Immunity, 2003
- Induction of Specific Cytotoxic Lymphocytes in Mice Vaccinated withBrucella abortusRB51Infection and Immunity, 2001
- Essential role of the VirB machinery in the maturation of the Brucella abortus-containing vacuoleCellular Microbiology, 2001
- CD8+ Type 1 CD44hi CD45 RBlo T lymphocytes control intracellular Brucella abortus infection as demonstrated in major histocompatibility complex class I‐ and class II‐deficient miceEuropean Journal of Immunology, 1995